209 related articles for article (PubMed ID: 25185684)
1. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease.
Saevik F; Nylund K; Hausken T; Ødegaard S; Gilja OH
Inflamm Bowel Dis; 2014 Nov; 20(11):2029-37. PubMed ID: 25185684
[TBL] [Abstract][Full Text] [Related]
2. Comparison between preoperative quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and operative macroscopic findings and results of histopathological scoring in Crohn's disease.
Girlich C; Jung EM; Huber E; Ott C; Iesalnieks I; Schreyer A; Schacherer D
Ultraschall Med; 2011 Apr; 32(2):154-9. PubMed ID: 20449794
[TBL] [Abstract][Full Text] [Related]
3. Non-Invasive Assessment of Inflammation and Treatment Response in Patients with Crohn's Disease and Ulcerative Colitis using Contrast-Enhanced Ultrasonography Quantification.
Socaciu M; Ciobanu L; Diaconu B; Hagiu C; Seicean A; Badea R
J Gastrointestin Liver Dis; 2015 Dec; 24(4):457-65. PubMed ID: 26697572
[TBL] [Abstract][Full Text] [Related]
4. Microcirculation and perfusion with contrast enhanced ultrasound (CEUS) in Crohn's disease: first results with linear contrast harmonic imaging (CHI).
Schreyer AG; Finkenzeller T; Gössmann H; Daneschnejad M; Müller-Wille R; Schacherer D; Zuber-Jerger I; Strauch U; Feuerbach S; Jung EM
Clin Hemorheol Microcirc; 2008; 40(2):143-55. PubMed ID: 19029639
[TBL] [Abstract][Full Text] [Related]
5. Assessment of inflammatory and fibrotic stenoses in patients with Crohn's disease using contrast-enhanced ultrasound and computerized algorithm: a pilot study.
Schirin-Sokhan R; Winograd R; Tischendorf S; Wasmuth HE; Streetz K; Tacke F; Trautwein C; Tischendorf JJ
Digestion; 2011; 83(4):263-8. PubMed ID: 21273775
[TBL] [Abstract][Full Text] [Related]
6. Early Predictors of the Long-term Response to Therapy in Patients With Crohn Disease Derived From a Time-Intensity Curve Analysis After Microbubble Contrast Agent Injection.
Quaia E; Gennari AG; Cova MA
J Ultrasound Med; 2019 Apr; 38(4):947-958. PubMed ID: 30208230
[TBL] [Abstract][Full Text] [Related]
7. Defining the ultrasound longitudinal natural history of newly diagnosed pediatric small bowel Crohn disease treated with infliximab and infliximab-azathioprine combination therapy.
Dillman JR; Dehkordy SF; Smith EA; DiPietro MA; Sanchez R; DeMatos-Maillard V; Adler J; Zhang B; Trout AT
Pediatr Radiol; 2017 Jul; 47(8):924-934. PubMed ID: 28421251
[TBL] [Abstract][Full Text] [Related]
8. The Role of Intravenous Contrast Agent in the Sonographic Assessment of Crohn's Disease Activity: Is Contrast Agent Injection Necessary?
Ripollés T; Martínez-Pérez MJ; Paredes JM; Vizuete J; Martin G
J Crohns Colitis; 2019 Apr; 13(5):585-592. PubMed ID: 30535070
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of bowel wall vascularisation in Crohn's disease with contrast-enhanced ultrasound and perfusion analysis.
Girlich C; Jung EM; Iesalnieks I; Schreyer AG; Zorger N; Strauch U; Schacherer D
Clin Hemorheol Microcirc; 2009; 43(1-2):141-8. PubMed ID: 19713608
[TBL] [Abstract][Full Text] [Related]
10. Associations between quantitative evaluation of bowel wall microvascular flow by contrast-enhanced ultrasound and indices of disease activity in Crohn's disease patients using both bolus and infusion techniques.
Zezos P; Zittan E; Islam S; Hudson J; Ben-Bassat O; Nazarian A; Steinhart HA; Silverberg MS; Atri M
J Clin Ultrasound; 2019 Oct; 47(8):453-460. PubMed ID: 31343081
[TBL] [Abstract][Full Text] [Related]
11. Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study.
Goertz RS; Klett D; Wildner D; Atreya R; Neurath MF; Strobel D
Acta Radiol; 2018 Oct; 59(10):1149-1156. PubMed ID: 29345146
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study.
Condino G; Calabrese E; Zorzi F; Onali S; Lolli E; De Biasio F; Ascolani M; Pallone F; Biancone L
Dig Liver Dis; 2013 Mar; 45(3):258-62. PubMed ID: 23195667
[TBL] [Abstract][Full Text] [Related]
13. Application of Dynamic Contrast-Enhanced Ultrasound in Evaluation the Activity of Crohn's Disease.
Wang Y; Wei L; Ge WS; Duan YR; Ding WJ; Lu XY; Huang YL; Chen S; Dong Y; Du P
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611585
[TBL] [Abstract][Full Text] [Related]
14. Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease.
Paredes JM; Ripollés T; Cortés X; Martínez MJ; Barrachina M; Gómez F; Moreno-Osset E
Dig Dis Sci; 2010 Feb; 55(2):404-10. PubMed ID: 19267199
[TBL] [Abstract][Full Text] [Related]
15. Long-term MRI-guided combined anti-TNF-α and thiopurine therapy for Crohn's perianal fistulas.
Tozer P; Ng SC; Siddiqui MR; Plamondon S; Burling D; Gupta A; Swatton A; Tripoli S; Vaizey CJ; Kamm MA; Phillips R; Hart A
Inflamm Bowel Dis; 2012 Oct; 18(10):1825-34. PubMed ID: 22223472
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn's disease: a comparison with surgical histopathology analysis.
Ripollés T; Rausell N; Paredes JM; Grau E; Martínez MJ; Vizuete J
J Crohns Colitis; 2013 Mar; 7(2):120-8. PubMed ID: 22483566
[TBL] [Abstract][Full Text] [Related]
17. Elective switching from infliximab to adalimumab in stable Crohn's disease.
Hoentjen F; Haarhuis BJ; Drenth JP; de Jong DJ
Inflamm Bowel Dis; 2013; 19(4):761-6. PubMed ID: 23446337
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of infliximab and adalimumab for Crohn's disease.
Osterman MT; Haynes K; Delzell E; Zhang J; Bewtra M; Brensinger C; Chen L; Xie F; Curtis JR; Lewis JD
Clin Gastroenterol Hepatol; 2014 May; 12(5):811-817.e3. PubMed ID: 23811254
[TBL] [Abstract][Full Text] [Related]
19. Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.
Paredes JM; Moreno N; Latorre P; Ripollés T; Martinez MJ; Vizuete J; Moreno-Osset E
Dig Dis Sci; 2019 Sep; 64(9):2600-2606. PubMed ID: 30874986
[TBL] [Abstract][Full Text] [Related]
20. Findings of ulceration and severe stricture on MRE can predict prognosis of Crohn's disease in patients treated with anti-TNF treatment.
Naganuma M; Okuda S; Hisamatsu T; Matsuoka K; Mori K; Hosoe N; Nakazato Y; Ogata H; Kanai T
Abdom Radiol (NY); 2017 Jan; 42(1):141-151. PubMed ID: 27549100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
